{
    "clinical_study": {
        "@rank": "156247", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "30 participants in this group receive a oral lactose placebo"
            }, 
            {
                "arm_group_label": "Lactobacilli", 
                "arm_group_type": "Active Comparator", 
                "description": "30 participants in this group receiving oral probiotic capsules for 7 days twice daily containing four lyophilised Lactobacillus strains belonging to the species:\nL.rhamnosus/ LbV96 (DSM 22560)\nL.jensenii /LbV 116 (DSM 22567)\nL.crispatus/ Lbv88 (DSM 22566)\nL.gasseri /LbV 150N (DSM 22583)"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is the improvement of the vaginal flora by at least two grades of the\n      Nugent scale after application of oral probiotics."
        }, 
        "brief_title": "The Ability of Orally Administered Lactobacillus Species to Improve the Quality of the Vaginal Flora of Women With Breast Cancer and Chemotherapy.", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Only women with breast cancer and neoadjuvant / adjuvant chemotherapy, at least 4 weeks\n        postoperative, without vaginal bleeding without abnormal vaginal discharge, Only women\n        with Nugent scores between 4 and 6\n\n        Exclusion Criteria:\n\n        Patients with diarrhoea, constipation, vaginal or urinary tract infection requiring\n        antibacterial treatment and women receiving antibiotic therapy in the previous 4 weeks."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 6, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01723592", 
            "org_study_id": "MUW EK 1417/2012"
        }, 
        "intervention": [
            {
                "arm_group_label": "Lactobacilli", 
                "description": "oral probiotic capsules for 7 days twice daily containing four lyophilised Lactobacillus strains", 
                "intervention_name": "Probiotics", 
                "intervention_type": "Dietary Supplement", 
                "other_name": [
                    "L.rhamnosus/ LbV96 (DSM 22560)", 
                    "L.jensenii /LbV 116 (DSM 22567)", 
                    "L.crispatus/ Lbv88 (DSM 22566)", 
                    "L.gasseri /LbV 150N (DSM 22583)"
                ]
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Oral lactose placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "chemotherapy", 
            "vaginal flora"
        ], 
        "lastchanged_date": "May 6, 2014", 
        "location": {
            "contact": {
                "email": "julian.marschalek@meduniwien.ac.at", 
                "last_name": "Julian Marschalek, MD", 
                "phone": "+431404002938"
            }, 
            "facility": {
                "address": {
                    "city": "Vienna", 
                    "country": "Austria", 
                    "zip": "1090"
                }, 
                "name": "Medical University of Vienna - Department of Obstetrics and Gynecology"
            }, 
            "investigator": {
                "last_name": "Ljubomir Petricevic, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Austria"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Ability of an Orally Administered Preparation of Four Lactobacillus Species to Improve the Quality of the Vaginal Flora of Women With Breast Cancer and Chemotherapy. A Prospective Randomized Placebo-controlled, Double-blind Trial", 
        "overall_contact": {
            "email": "ljubomir.petricevic@meduniwien.ac.at", 
            "last_name": "Ljubomir Petricevic, MD", 
            "phone": "+431404002938"
        }, 
        "overall_contact_backup": {
            "email": "julian.marschalek@meduniwien.ac.at", 
            "last_name": "Julian Marschalek, MD", 
            "phone": "+431404002938"
        }, 
        "overall_official": {
            "affiliation": "Medical University of Vienna, Dept. of Obstetrics and Gynecology", 
            "last_name": "Herbert Kiss, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Austria: Ethikkommission", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Using Nugent scoring system, from each participant first swab from the vagina will be taken before start of oral probiotic use.(baseline information) Second swab will be taken on the day following the last administration.(information about change in Nugent)", 
            "measure": "change in Nugent score between baseline and end of treatment (improvement or no improvement)", 
            "safety_issue": "No", 
            "time_frame": "day 0, 7 and day 14 of oral probiotic application"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01723592"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical University of Vienna", 
            "investigator_full_name": "Assistant Prof. Ljubomir Petricevic MD", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "From each participant, a vaginal swab for microbiologic cultures will be taken on the first day and that following the last administration for Isolation of oral applied probiotic strains as well as non-lactobacilli-flora.", 
            "measure": "Isolation of specific Lactobacilli from vaginal microbiologic cultures after oral administration of probiotic", 
            "safety_issue": "No", 
            "time_frame": "day 0, 7 and day 14 after oral probiotic application"
        }, 
        "source": "Medical University of Vienna", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Natural Resources and Life Sciences, Vienna, Austria", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Medical University of Vienna", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}